Your browser doesn't support javascript.
loading
A multi-center analysis of individuals with a 47,XXY/46,XX karyotype.
Guess, Tiffany; Wheeler, Ferrin C; Yenemandra, Ashwini; Schilit, Samantha L P; Anderson, Hannah S; Bone, Kathleen M; Carstens, Billie; Conlin, Laura; Dulik, Matthew C; Dupont, Barbra R; Fanning, Elizabeth; Gardner, Juli-Anne; Haag, Mary; Hilton, Benjamin A; Johnson, Jill; Kogan, Jillene; Murry, Jacyln; Polonis, Katarzyna; Quigley, Denise I; Repnikova, Elena A; Rowsey, Ross A; Spinner, Nancy; Stoeker, Mikayla; Thurston, Virginia; Wiley, Margaret; Zhang, Lei.
Afiliação
  • Guess T; Molecular Pathology Laboratory Network, Maryville, TN; Department of Pathology, Vanderbilt University Medical Center, Nashville, TN. Electronic address: tguess@mplnet.com.
  • Wheeler FC; Department of Pathology, Vanderbilt University Medical Center, Nashville, TN.
  • Yenemandra A; Department of Pathology, Vanderbilt University Medical Center, Nashville, TN.
  • Schilit SLP; Division of Clinical Cytogenetics, Center for Advanced Molecular Diagnostics, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Anderson HS; ARUP Laboratories, Salt Lake City, UT; Department of Human Genetics, University of Utah, Salt Lake City, UT.
  • Bone KM; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
  • Carstens B; Colorado Genetics Laboratory, Department of Pathology, University of Colorado, Anschutz Medical Center, Aurora, CO.
  • Conlin L; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, PA.
  • Dulik MC; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, PA.
  • Dupont BR; Greenwood Genetic Center, Greenwood, SC.
  • Fanning E; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, PA.
  • Gardner JA; Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT.
  • Haag M; Colorado Genetics Laboratory, Department of Pathology, University of Colorado, Anschutz Medical Center, Aurora, CO.
  • Hilton BA; Greenwood Genetic Center, Greenwood, SC.
  • Johnson J; Greenwood Genetic Center, Greenwood, SC.
  • Kogan J; Advocate Clinical Laboratories, Advocate Health, Rosemont, IL.
  • Murry J; Johns Hopkins University School of Medicine, Baltimore, MD.
  • Polonis K; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Quigley DI; ARUP Laboratories, Salt Lake City, UT.
  • Repnikova EA; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital Kansas City, MO.
  • Rowsey RA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Spinner N; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, PA.
  • Stoeker M; Colorado Genetics Laboratory, Department of Pathology, University of Colorado, Anschutz Medical Center, Aurora, CO.
  • Thurston V; Advocate Clinical Laboratories, Atrium Health, Charlotte, NC.
  • Wiley M; GeneDx Sema4, Stamford, CT.
  • Zhang L; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital Kansas City, MO.
Genet Med ; : 101212, 2024 Jul 13.
Article em En | MEDLINE | ID: mdl-39011769
ABSTRACT

INTRODUCTION:

Klinefelter syndrome (KS), a sex chromosome aneuploidy, is associated with a 47,XXY chromosomal complement and is diagnosed in ∼1600 live male births. Individuals with a 46,XX cell line in addition to 47,XXY are less common with a limited number of published case reports.

METHODOLOGY:

To better understand the implications of a 47,XXY/46,XX karyotype, we conducted a retrospective, multi-center analysis of the cytogenetic findings and associated clinical records of 34 patients diagnosed with this SCA across 14 institutions.

RESULTS:

Presence of the XX cell line ranged from 5-98% in patient specimens. Phenotypes also exhibited significant heterogeneity with some reporting a single reason for referral and others presenting with a constellation of symptoms, including ambiguous genitalia and ovotestes. Ovotestes were present in 12% of individuals in this cohort, who had a significantly higher percentage of XX cells. Notably, two patients were assigned female sex at birth

DISCUSSION:

These findings highlight the variability of the clinical phenotypes associated with this SCA as well as the challenges of clinical management for this population. Karyotype or FISH analysis, which offer single-cell resolution, rather than chromosomal microarray or molecular testing, is the ideal test strategy in these instances as mosaicism can occur at low levels.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article